Clinical Trials
3 trialsNCT04666038 2026-04-24
BRUIN CLL-321
Eli Lilly and Company
Phase 3 Active not recruiting
NCT01796470 2020-06-02
Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies
Gilead Sciences
Phase 2 Terminated
NCT00710528 2012-08-31
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
Gilead Sciences
Phase 1 Completed